Abstract Objectives This study is among the first to examine metropolitan status differences in human papillomavirus (HPV) vaccine initiation and completion among United States adolescent girls and is unique in its focus on how maternal socioeconomic status and health care access moderate metropolitan status differences in HPV vaccination. Methods Using cross-sectional data from 3573 girls aged 12-17 in the U.S. from the 2008-2010 Behavioral Risk Factor Surveillance System, we estimate main and interaction effects from binary logistic regression models to identify subgroups of girls for which there are metropolitan versus non-metropolitan differences in HPV vaccination. Results Overall 34 % of girls initiated vaccination, and 19 % completed all three shots. On average, there were no metropolitan status differences in vaccination odds. However, there were important subgroup differences. Among low-income girls and girls whose mothers did not complete high school, those in non-metropolitan areas had significantly higher probability of vaccine initiation than those in metropolitan areas. Among high-income girls and girls whose mothers completed college, those in metropolitan areas had significantly higher odds of vaccine initiation than those in non-metropolitan areas. Moreover, among girls whose mothers experienced a medical cost barrier, non-metropolitan girls were less likely to initiate vaccination compared to metropolitan girls. Conclusions Mothers remain essential targets for public health efforts to increase HPV vaccination and combat cervical cancer. Public health experts who study barriers to HPV vaccination and physicians who come into contact with mothers should be aware of group-specific barriers to vaccination and employ more tailored efforts to increase vaccination.
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Significance
There are significant metropolitan status disparities in cervical cancer mortality, and widespread use of the HPV vaccine could reduce these disparities. Yet studies on
Introduction
The human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the United States, and virtually all cases of cervical cancer are caused by HPV. It is now widely accepted that HPV vaccination offers tremendous potential for prevention of HPV-related pre-cancers and cancers and could substantially reduce cervical cancer mortality [31] . The U.S. Advisory Committee on Immunization Practices recommends three doses of quadrivalent HPV vaccine be administered to girls starting at ages 11 or 12 [16] . Yet, there is widespread variation in vaccination among adolescent girls, ranging in recent studies from 9 to 37 % for initiation and 2-28 % for completion (CDC 2000 ; [6, 9, 17, 24, 32, 33] ). One factor that may be an important determinant of variation is metropolitan status. Research has found significant rural disparities in cervical cancer rates and prevention [4, 21, 28] . Unfortunately, most studies examining correlates of HPV vaccination do not disaggregate results by metropolitan status. In one recent study that included both metropolitan and non-metropolitan parents, [24] researchers have found parents' beliefs about HPV vaccination for their daughters were largely consistent across metropolitan status. However, there is a paucity of research identifying factors that influence metropolitan status differences in actual HPV vaccination [5] . Studies that have examined these differences have been limited by the use of small data sets restricted to specific samples of girls or one specific geographic area [18, 22, 27] .
Using a large sample of adolescent girls living in metropolitan and non-metropolitan areas in nine U.S. states, the current study seeks to identify different conditions under which metropolitan status differences in HPV vaccination may exist. Although non-metropolitan areas have historically been medically underserved in prevention services [34] those disparities have been largely tempered by the introduction of federally funded community health centers [1, 23] . This suggests metropolitan and nonmetropolitan girls may have similar access to preventive health services, including the HPV vaccine [27] . In addition, most health insurance providers now cover the HPV vaccination, and most adolescents who are uninsured, underinsured, or Medicaid-eligible are covered by the federal Free Vaccines for Children Program (VFC) (CDC [7] , suggesting that variation in children's insurance coverage across metropolitan and non-metropolitan places should play less of a role in HPV vaccination than in other types of adolescent health service use.
Beyond insurance status, however, it is clear from previous research that mothers and physicians play essential roles in facilitating vaccination. Maternal acceptability of vaccination is among the strongest predictors of adolescent acceptance, interest, and vaccine initiation [25] . Moreover, daughters of women who engage in their own preventive health practices are more likely to get the vaccine than daughters of women who do not engage in these practices [9, 17] . Given the importance of physician recommendation in facilitating vaccination [5, 24] , mothers' opportunities to interact with physicians could play a major role in whether their daughters get vaccinated. Therefore, mothers' own access to health care and socioeconomic status (SES) may be important factors in eventual physician referral for vaccination and mothers acting on that referral. Although previous research included maternal SES and health care access as predictors of adolescent vaccination [13, 26, 33] , the relative significance of these factors were mixed, and no study has examined whether metropolitan versus non-metropolitan differences in vaccination are conditional upon mothers' SES or health care access. Accordingly, our study aims to advance the literature on understanding predictors of adolescent HPV vaccination by (1) identifying whether there are metropolitan status differences in vaccine initiation and completion among adolescent girls, and (2) determining whether maternal SES and health care access moderate metropolitan status differences in vaccination status.
Methods Sample
This cross-sectional study used data from the 2008, 2009, and 2010 Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS is the world's largest telephone health survey, tracking adult health behaviors, health care use, and health outcomes from all U.S. states and Washington, DC. In 2008-2010, the BRFSS included an adolescent HPV vaccination module as an option for states to include in their annual survey dissemination. Over the 3 years, ten states (Connecticut, Delaware, Kentucky, New York, Oklahoma, Pennsylvania, Texas, West Virginia, Wisconsin, and Wyoming) incorporated the module. The core survey questions and HPV module questions were identical for nine of these states, 1 enabling us to pool the 3 years of data. More information about the BRFSS is available at http://www.cdc.gov/brfss/.
One child from each sampled household was randomly selected, and the sampled adult within the household answered questions about the child. Because we were interested in the extent to which maternal SES and health care access moderate metropolitan status differences in vaccination, we restricted our analysis to female respondents who served as the maternal figure in the household [i.e., those who identified their relationship as parent (95 %), grandparent (4 %), or foster parent/guardian (1 %)]. For ease, we use the terms 'mother' and 'maternal' to refer to these groups. We restricted our study to girls aged 12-17 because research suggests that the optimal time for girls to receive the vaccine is age 11 or 12 when their bodies produce the strongest antibody response and because this is an age before most girls become sexually active (CDC [8] ). After listwise deletion of cases missing on variables of interest 2 (7.5 % of eligible cases), our sample size was 3573.
A distribution of our sample of respondents by state is shown in Table 1 . Our analyses accounted for the complex sampling design of the BRFSS (strata), and we used poststratification weights to correct for selection, nonresponse, and telephone coverage bias. This study was exempted from institutional review board review by the lead author's institution.
Measures

Vaccine Initiation and Completion
Our outcomes were HPV vaccine initiation and completion. Initiation was based on the BRFSS question: ''A vaccine to prevent the human papillomavirus or HPV infection is available and is called the cervical cancer vaccine, HPV shot, or GARDISIL. Has the child EVER had the HPV vaccination?'' with the options of 'yes' versus 'no'. A follow-up question asked, ''How many shots did she receive?'' Because the HPV vaccine is administered as a three-shot series, we dichotomized this item to indicate whether the girl had received all three shots.
Metropolitan Status
Our independent variable was metropolitan status. Although the BRFSS provides the county identifier (i.e., FIPs code) for the majority of respondents that would enable us to identify the specific county rural-urban continuum code developed by USDA's Economic Research Service [30] , the BRFSS masks these codes for respondents living in counties with fewer than 50 respondents or 10,000 residents. Rather than exclude these respondents from our analysis and risk systematically excluding residents from the most rural counties, we elected to use the metropolitan status variable provided in the BRFSS rather than the county FIPs codes to identify metropolitan status. The BRFSS places respondents into one of five different categories: center city of a metropolitan statistical area (MSA), outside the center city of an MSA but inside the county containing the center city, inside a suburban county of the MSA, in an MSA that has no center city, and not in an MSA. Due to small sample sizes in some categories, and because we were interested in metropolitan/non-metropolitan differences, we collapsed all respondents living in an MSA into one category identified as 'metropolitan' and compared them to respondents who do not live in an MSA ('nonmetropolitan'). Suburban residents are included in the 'metropolitan' category. We acknowledge as a limitation our inability to distinguish between those living in large non-metropolitan counties and those living in small, remote rural places.
Maternal Socioeconomic Status and Health Care Access
We were interested in the extent to which mother's SES and access to health care condition metropolitan status differences in vaccination. Accordingly, we included household income, educational attainment, health insurance (any form of health insurance vs. none), experience with a medical cost barrier in the past year (mother reported that there was a time in the past year when she needed to see a doctor but could not because of cost), and whether the mother had at least one personal doctor.
Covariates
Based on previous HPV vaccination research, we adjusted our regression models for adolescent age, mother's age, marital status, number of adults and children in the household, employment status, whether the mother received a routine physical health checkup in the past 2 years, whether the mother had a pap test in the past 3 years, and mother's race/ethnicity. Although adolescent 1 We excluded respondents from NY because NY excluded the question about number of HPV shots received, disabling us from identifying which girls completed the series. 2 Rather than excluding respondents who were missing on income (N = 301), we created a dummy variable in order to keep them in our analyses. Excluding these respondents would introduce systematic bias into the results because girls of respondents missing on income were significantly less likely to be vaccinated than those not missing income.
race/ethnicity was also available, it was strongly correlated with mother's race/ethnicity. We ran separate models, exchanging adolescent race/ethnicity for mother's race/ ethnicity, and the results were unchanged. We included state-level fixed effects to control for unobserved statelevel characteristics, including state variation in HPV statutes.
Statistical Analysis
We first present percentages of respondents in each state who indicated daughters initiated and completed the HPV vaccine for the complete sample and by metropolitan status (Table 1) . We used adjusted Wald tests to indicate where significant differences exist. We then present descriptive statistics for all variables for the full sample and by metropolitan status (Table 2) . We used unadjusted and adjusted binary logistic regression models to calculate odds ratios (ORs) and 95 % confidence intervals (CIs) for vaccine initiation (Table 3) . Among those who began the vaccine (N = 1390), we used the same regression models to calculate ORs and 95 % CIs for completing the three-shot series (Table 4) . Finally, we ran five interaction models for each outcome to determine the extent to which metropolitan status differences in HPV vaccination are conditional on maternal SES and health care access (coefficients available in Appendix). We present average predicted probabilities from significant interactions in Figs. 1, 2, 3 and effect sizes of differences between subgroups in Table 5 . We tested for multicollinearity; no problems were detected. Data were analyzed using SAS version 9.4 (SAS Enterprises, Inc., Cary, NC).
Results
Results from Table 1 indicate that although most states have noticeable metropolitan status differences in vaccine initiation and completion, the only difference that is statistically significant (at the p \ 0.05 level) is for Oklahoma, where initiation was significantly higher among nonmetropolitan compared to metropolitan girls. 3 Descriptive statistics for the sample are presented in Table 2 . Thirty-four percent of girls started the vaccine, and 55 % of those who initiated vaccination completed all three shots (19 % of all girls). Chi square tests indicated no significant differences in vaccine initiation or completion among girls in metropolitan versus non-metropolitan areas.
Results from unadjusted models for vaccine initiation are shown in the first column of Table 3 . Here we found no significant metropolitan status difference in vaccine initiation. The addition of covariates did not change this finding. We found several important maternal-related correlates. Girls in the $50,000-$74,999 household income category had significantly lower odds of vaccine initiation compared to those in the highest income category, and girls whose mothers have less than a high school education had significantly lower odds of vaccine initiation than girls whose mothers have a college degree. In addition, mother's access to a personal doctor was associated with 45 % greater odds of vaccine initiation in the adjusted model. Results from unadjusted and adjusted regression models for vaccine completion (among vaccine initiates) are shown in Table 4 . Again we found no significant metropolitan status difference in vaccine completion in either the unadjusted or adjusted models, but unlike with initiation, maternal SES and health care access were not associated with vaccine completion. 4 Adolescent age was positively associated with both vaccine initiation and completion. Hispanics had significantly greater odds of vaccine initiation than whites, but 'other race' respondents had significantly lower odds of vaccine completion than whites.
We next conducted a series of interaction models where we tested whether metropolitan status differences in vaccine initiation and completion were conditional on mother's SES and health care access (household income, educational attainment, health insurance status, experience with a medical cost barrier in the past year, and whether mother has at least one personal doctor). Coefficients (logodds) from adjusted models are presented in the Appendix. Weighted; SD standard deviation, p probability of rejecting null hypothesis of no difference using two-tailed Wald tests for interval-ratio variables and Chi square tests for categorical variables 4 In the unadjusted model for vaccine completion, girls whose mothers had a high school degree had significantly lower odds (p \ 0.05) of vaccine completion versus girls whose mothers had a college degree. In the adjusted model, that significant difference was eliminated. We found that income alone resulted in the elimination of significance of the high school versus college difference.
We present predicted probabilities (Figs. 1, 2, 3 ) and effect sizes (Table 5 ) from the models with significant interactions. We found no significant interactions for vaccine completion, but we found three important interactions for vaccine initiation. First, as shown in Fig. 1 , metropolitan status differences were moderated by household income, net of all covariates. Among low-income households, non-metropolitan girls had significantly greater average probability of vaccine initiation than metropolitan girls (d = -0.340), but among high-income households, metropolitan girls had significantly greater average probability of vaccine initiation than non-metropolitan girls (d = 0.781). Second, as shown in Fig. 2 , metropolitan status differences were moderated by mother's educational attainment, net of all covariates. Among girls with low-education mothers, metropolitan girls had significantly lower average probability of vaccine initiation than non-metropolitan girls (d = -1.325), but among girls whose mothers have a college degree or more, metropolitan girls had significantly higher average probability of vaccine initiation (d = 0.893). Surprisingly, non-metropolitan girls whose mothers have less than high school had the highest average probability of vaccine initiation, holding all else constant. Finally, we found an interaction approaching conventional statistical significance for mother's experience with a medical cost barrier in the past year (p = 0.056) (Fig. 3) . Among girls whose mothers did not experience a cost barrier in the past year, there were no significant metropolitan status differences in initiation, but among Weighted; adjusted model also controls for state fixed effects; OR odds ratio, CI 95 % confidence interval, p probability of rejecting null hypothesis of no difference girls whose mothers did experience a cost barrier in the past year, girls living in metropolitan areas were more likely than girls living in non-metropolitan areas to have begun the vaccine; non-metropolitan girls experience a greater penalty when their mothers have a medical cost barrier than do metropolitan girls.
Discussion
Our study is among the first to examine metropolitan status differences in HPV vaccination and is unique in its focus on how maternal SES and health care access condition metropolitan status differences in vaccination. Consistent with other recent research using samples from North Carolina [18] and safety net clinics [27] , we found no metropolitan status differences in adolescent vaccination, on average. However, we extend the research in this area by finding important subgroups for which metropolitan status differences are significant and substantial. First, higher SES facilitates daughter's vaccine initiation, but only in metropolitan areas. Previous studies on the role of parental SES generally find that parents with lower levels of education are more likely to accept HPV vaccination for their daughters [5, 26] , and to have their daughters vaccinated [33] . Our findings for nonmetropolitan girls were in line with these previous studies, suggesting that mother's higher SES is not a facilitator of HPV vaccination for girls living in non-metropolitan areas. Surprisingly, among non-metropolitan girls, those from the lowest income and lowest education households had the highest probability of vaccine initiation. These findings suggest that spatial context plays an important role in the relationship between SES and adolescent vaccination. There are many potential explanations for these findings. First, it may be that non-metropolitan doctors for low-SES mothers are more likely than doctors of high-SES mothers to view the daughters of these women as having greater risk for contracting HPV due to relatively younger ages at first sexual intercourse and greater likelihood of sexual risk-taking among low-SES girls, especially in rural areas [3, 14] . They may therefore be more likely to recommend vaccination for those girls.
Second, trust in medical authorities is associated with greater likelihood of parental acceptance of the HPV vaccine [19] . It may be that low-SES non-metropolitan mothers have a more traditional patient-doctor relationship, wherein the doctor is viewed as an authority figure and expert. Moreover, research shows physician trust is significantly lower among low-SES urban women [2] , and low-SES women in non-metropolitan areas may have more stable and long-term relationships with their physicians than those in metropolitan areas. These relationships may facilitate physician recommendation of vaccination [11, 12, 15] . Given that our SES-interaction findings hold net of controlling for having a personal doctor, the quality of the relationship a woman has with her doctor may be more important in facilitating daughter's vaccination than simply having a personal provider. Unfortunately, the BRFSS does not ask about physician change or length of time with personal doctors. Future research should examine how differences in continuity of care relate to metropolitan status differences in HPV vaccination.
We also found an interaction for mother's experience with a medical cost barrier in the past year; mother's experience with a medical cost barrier is a disabling factor for girls living in non-metropolitan areas, but not those in metropolitan areas. Because the vaccine is covered by most insurance companies or through the FVC program, we think this finding is not about the cost of the vaccine, but may be related to the barriers low-income non-metropolitan mothers face with actually getting their daughters to the doctor. The cost of transportation in areas where the physician's office is several miles away might be a barrier more commonly faced by non-metropolitan than metropolitan mothers. That this finding holds net of controlling for health insurance also suggests this finding is about more than the cost of the vaccination. Unfortunately, the BRFSS data do not enable us to distinguish type of health insurance or gaps in coverage. Beyond the important role of physicians, our findings may also be explained by factors we are unable to test with the data available. These include differences in religious and cultural beliefs that may influence parents' decisions about vaccination for their children. It is worrisome that girls from the middle-upper income group ($50,000-$75,000) were the least likely to initiate vaccination in both metropolitan and non-metropolitan areas. This 'middle-upper class' group may be increasingly resistant to vaccination in general [29] . It is also possible that this group represents families who are working long hours and are engaged in multiple extramural activities with their children, resulting in time restrictions that may reduce what some parents view as unnecessary visits to physicians.
It is striking that although we found significant interactions for vaccine initiation, these interactions did not hold for vaccine completion. The mechanisms facilitating completion are likely quite different from those facilitating initiation. Whereas initiation can begin during an annual wellchild visit or at the time of the girl's first vaginal examination, there may be challenges associated with getting the daughter to an appointment for the second dose at 2 months and third dose at 6 months. New innovations in vaccine delivery, including advances toward a vaccine that could be administered in one dose, would likely increase vaccine completion rates and decrease disparities in completion.
Our results should be considered in light of some limitations. First, only nine states incorporated the optional child HPV module. Thus, our findings are not generalizable to the U.S. population. In particular, our study over-represents Hispanics and underrepresents Blacks. Given that Hispanics were more likely than whites to initiate vaccination, our results may overestimate average vaccine initiation in the population. Still, our percentages for initiation and completion (34 and 19 %) are in line with previous research using similar age groups [9, 10] . Similarly, the BRFSS is a phone survey and likely underrepresents populations without telephones or who refuse to complete surveys via phone. However, we do include the BRFSS design weight in our analyses, which adjusts for probability of selection and phone ownership.
Though the purpose of this study was not to explain state-level variation in vaccination, descriptive results demonstrate state-by-state and within-state differences in vaccination. Some of these may be explained by vaccine mandates. Since 2006, at least 25 states have enacted HPV legislation to require or fund the vaccine or educate school children about HPV, including Texas and Wisconsin, two states included in our sample (NCSL [20] ). Vaccination initiation and completion would likely be higher a sample that included respondents from more states that have implemented these statutes. Despite this limitation, our regression models do account for these differences with state fixed effects.
Data limitations also prevented us from including variables that have been found to be important predictors of vaccination in previous research, the most important of which may be physician recommendation. Moreover, we were unable to break down non-metropolitan residence into finer degrees of rurality. There are likely differences between residents of very remote rural areas and those in larger non-metropolitan communities, especially if they are adjacent to urban centers. Relatedly, we were unable to control for contextual conditions, including health care supply and access. The supply of and distance to health care providers, access to public transportation, and local responses (e.g., local deployment of HPV task forces, a rapid response to high incidence of HPV, a particular OBGYN or family physician who is championing the vaccine) may all play a role in explaining spatial variation in vaccination. Data on such contextual predictors of variation are not available, and we encourage researchers to undertake this important data compilation and analysis effort. Despite these limitations, our study advances research on correlates of adolescent HPV vaccination in important ways. Although not nationally representative, it extends studies restricted to specific states or specific groups (e.g., college students, managed care enrollees) to a more general population of adolescent girls. Further, whereas previous research on metropolitan status differences in parental attitudes or intent to vaccinate have been important in helping to inform interventions for educating parents, our focus on actual vaccine initiation and completion provides insight into the conditions under which metropolitan status differences in actual vaccination occur. The finding that vaccine initiation was relatively high among low-SES non-metropolitan girls is encouraging, both because cervical cancer prevalence is higher in nonmetropolitan areas [4, 28] and because low-SES is associated with increased incidence of cervical cancer [4] . It may be that doctors are encouraging mothers of these atrisk girls to have their daughters vaccinated. Future research should focus on identifying strategies for increasing continuity of care among metropolitan mothers or finding different mechanisms through which recommendations, reminders, and follow-ups can occur.
Ultimately, one-size-fits-all interventions may be less effective at increasing vaccination than interventions that are more spatially and demographically targeted. In particular, our findings about the divergent role of mother's SES in vaccine initiation for girls in metropolitan versus non-metropolitan areas suggests that future researchers should avoid broad generalizations about the associations between parents' SES and daughters' vaccination status.
